MXPA03007272A - Formulacion de medicamento que contiene agonista muscarinico. - Google Patents
Formulacion de medicamento que contiene agonista muscarinico.Info
- Publication number
- MXPA03007272A MXPA03007272A MXPA03007272A MXPA03007272A MXPA03007272A MX PA03007272 A MXPA03007272 A MX PA03007272A MX PA03007272 A MXPA03007272 A MX PA03007272A MX PA03007272 A MXPA03007272 A MX PA03007272A MX PA03007272 A MXPA03007272 A MX PA03007272A
- Authority
- MX
- Mexico
- Prior art keywords
- formulation containing
- muscarinic agonist
- medicament formulation
- medicament
- muscarinic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10106971A DE10106971A1 (de) | 2001-02-15 | 2001-02-15 | Arzneimittelformulierung die einen muskarinischen Agonisten enthält |
| PCT/EP2002/001374 WO2002064124A2 (de) | 2001-02-15 | 2002-02-09 | Arzneimittelformulierung die einen muskarinischen agonisten enthält |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03007272A true MXPA03007272A (es) | 2003-12-04 |
Family
ID=7674095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03007272A MXPA03007272A (es) | 2001-02-15 | 2002-02-09 | Formulacion de medicamento que contiene agonista muscarinico. |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP1361871A2 (es) |
| JP (1) | JP2004518710A (es) |
| AR (1) | AR033862A1 (es) |
| AU (1) | AU2002247705A1 (es) |
| CA (1) | CA2434976A1 (es) |
| DE (1) | DE10106971A1 (es) |
| MX (1) | MXPA03007272A (es) |
| UY (1) | UY27170A1 (es) |
| WO (1) | WO2002064124A2 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101652139A (zh) * | 2007-03-29 | 2010-02-17 | 第一三共株式会社 | 药物组合物 |
| WO2010033045A1 (en) * | 2008-09-16 | 2010-03-25 | Igor Anatolievich Pomytkin | Compositions and methods for prevention or treatment of beta amyloid deposition |
| WO2011115067A1 (ja) | 2010-03-19 | 2011-09-22 | 第一三共株式会社 | 抗凝固剤の溶出改善方法 |
| CN103732227B (zh) | 2011-08-10 | 2017-04-12 | 第一三共株式会社 | 含有二胺衍生物的药物组合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE8817121U1 (de) * | 1988-11-22 | 1993-02-04 | Boehringer Ingelheim Kg, 55218 Ingelheim | Neue Quinuclidine |
| AU5716898A (en) * | 1997-01-08 | 1998-08-03 | Warner-Lambert Company | Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease |
| AU6896098A (en) * | 1997-04-11 | 1998-11-11 | Eli Lilly And Company | Method for treating schizophrenia |
| AU7247898A (en) * | 1997-04-11 | 1998-11-11 | Eli Lilly And Company | Composition for treating pain |
| DE19851126A1 (de) * | 1998-11-06 | 2000-05-11 | Boehringer Ingelheim Pharma | Verwendung von Talsaclidin zur Behandlung der Schizophrenie |
-
2001
- 2001-02-15 DE DE10106971A patent/DE10106971A1/de not_active Withdrawn
-
2002
- 2002-02-09 AU AU2002247705A patent/AU2002247705A1/en not_active Abandoned
- 2002-02-09 CA CA002434976A patent/CA2434976A1/en not_active Abandoned
- 2002-02-09 WO PCT/EP2002/001374 patent/WO2002064124A2/de not_active Application Discontinuation
- 2002-02-09 MX MXPA03007272A patent/MXPA03007272A/es unknown
- 2002-02-09 JP JP2002563919A patent/JP2004518710A/ja active Pending
- 2002-02-09 EP EP02716755A patent/EP1361871A2/de not_active Withdrawn
- 2002-02-13 UY UY27170A patent/UY27170A1/es not_active Application Discontinuation
- 2002-02-15 AR ARP020100515A patent/AR033862A1/es not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2434976A1 (en) | 2002-08-22 |
| UY27170A1 (es) | 2002-09-30 |
| AU2002247705A1 (en) | 2002-08-28 |
| WO2002064124A3 (de) | 2002-12-05 |
| AR033862A1 (es) | 2004-01-07 |
| EP1361871A2 (de) | 2003-11-19 |
| JP2004518710A (ja) | 2004-06-24 |
| WO2002064124A2 (de) | 2002-08-22 |
| DE10106971A1 (de) | 2002-08-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0108228D0 (en) | Medicament dispenser | |
| GB0108213D0 (en) | Medicament dispenser | |
| GB0114175D0 (en) | Medicament dispenser | |
| GB0108215D0 (en) | Medicament dispenser | |
| GB0108208D0 (en) | Medicament dispenser | |
| GB0130284D0 (en) | Medicament dispenser | |
| GB0130857D0 (en) | Medicament dispenser | |
| GB0125134D0 (en) | Medicament dispenser | |
| MXPA03006775A (es) | Formulacion farmaceutica. | |
| MXPA03003853A (es) | Abastecedor de medicamentos. | |
| TWI319326B (en) | Stable high -concentration injection containing 3-methyl-1-phenyl-2-pyrazolin-5-one | |
| GB0122725D0 (en) | Drug dispensing components | |
| ZA200402729B (en) | Pharmaceutical formulation comprising (R) -bicalutamide. | |
| AP2003002783A0 (en) | Medicament containing activted antihtrombin iii | |
| MXPA03007272A (es) | Formulacion de medicamento que contiene agonista muscarinico. | |
| GB0110485D0 (en) | Medicament dispenser | |
| ZA200402731B (en) | Pharmaceutical formulation. | |
| GB0119850D0 (en) | Medicament dispenser | |
| GB0116891D0 (en) | Medicament dispenser | |
| GB0114176D0 (en) | Medicament dispenser | |
| GB0100998D0 (en) | Medicament dispenser | |
| AU2002346984A1 (en) | Medicament dispenser | |
| AU2002346985A1 (en) | Medicament dispenser | |
| AU2002249394A1 (en) | Medicament dispenser | |
| AU2002250928A1 (en) | Medicament dispenser |